Xiaofei Liang

Xiaofei Liang


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 June 2018 in Journal of Materials Chemistry C
Verified
Journal Article
Closed access
PDF file
NSNa Song
Na Song
HPHaidong Pan
Haidong Pan
XLXiaofei Liang
Xiaofei Liang
DCDonglei Cao
Donglei Cao
LSLiyi Shi
Liyi Shi
PDPeng Ding
Peng Ding
With the development of miniaturized and highly integrated of microelectronic products, it has become particularly important to fabricate a thermally conductive, electrically insulating and environment-friendly composite as a thermal interface material (TIM) for heat dissipation. Here, we designed the structure of a multilayer thermally conductive hybrid film based on nanofibrillated cellulose and fillers (graphene and boron nitride) using the vacuum-assisted layer-by-layer (VA-LBL) self-assembly technique. Fully unifying the advantages of the thermally conductive three-layer electrically insulating film and an antistatic film, the ordered five-layer thermally conductive film (7.04 W m−1 K−1 with 8 wt% fillers) exhibits a comprehensive performance with electrically insulating and antistatic properties, which simultaneously has an excellent tensile strength (172 MPa). Therefore, it could be applied as a TIM for various thermal management applications with diverse requirements in a safe and environmentally friendly manner.

31 August 2016 in Analytical Chemistry
Verified
Journal Article
Open access
JDJian Ding
Jian Ding
KWKai Wang
Kai Wang
WTWenjie Tang
Wenjie Tang
DLDan Li
Dan Li
YWYou-Zhen Wei
You-Zhen Wei
XLXiaofei Liang
Xiaofei Liang
Highly effective targeted tumor recognition via vectors is crucial for cancer detection. In contrast to antibodies and proteins, peptides are direct targeting ligands with a low molecular weight. In the present study, a peptide magnetic nanovector platform containing a lipid bilayer was designed using a peptide amphiphile (PA) as a skeleton material in a controlled manner without surface modification. Fluorescein isothiocyanate-labeled epidermal growth factor receptor (EGFR) peptide nanoparticles (NPs) could specifically bind to EGFR-positive liver tumor cells. EGFR peptide magnetic vesicles (EPMVs) could efficiently recognize and separate hepatoma carcinoma cells from cell solutions and treated blood samples (ratio of magnetic EPMVs versus anti-EpCAM NPs: 3.5 ± 0.29). Analysis of the circulating tumor cell (CTC) count in blood samples from 32 patients with liver cancer showed that EPMVs could be effectively applied for CTC capture. Thus, this nanoscale, targeted cargo-packaging technology may be useful for designing cancer diagnostic systems.

18 November 2020 in Journal of Nanobiotechnology
Verified
Journal Article
Open access
PDF file
YZYang Zhao
Yang Zhao
FJFeng Jiang
Feng Jiang
QWQinhua Wang
Qinhua Wang
BWBaocheng Wang
Baocheng Wang
YHYipeng Han
Yipeng Han
JMjie ma
jie ma
Background: It is very important to develop a highly efficient cerebrospinal fluid (CSF) detection system with diagnosis and prediction function, for which the detection of circulating tumor cells (CTCs) in CSF is a good choice. In contrast to the past use of epithelial EpCAM as CTCs separation target, a cytoplasm protein of GFAP antibody was first selected to construct highly-sensitive immunomagnetic liposome beads (IMLs). The validation and efficiency of this system in capturing CTCs for brain tumors were measured both in vitro and in vivo. The associations between the numbers of CTCs in patients with their clinical characteristics were further analyzed. Results: Our data show that CTCs can be successfully isolated from CSF and blood samples from 32 children with brain tumors. The numbers of CTCs in CSF were significantly higher than those in blood. The level of CTCs in CSF was related to the type and location of the tumor rather than its stage. The higher the CTCs number is, the more possibly the patient will suffer from poor prognosis. Genetic testing in GFAP CTC-DNA by sanger sequencing, q-PCR and NGS methods indicated that the isolated CTCs (GFAP+/EGFR+) are the related tumor cell. For example, the high expression of NPR3 gene in CSF CTCs was consistent with that of tumor tissue. Conclusions: The results indicated that GFAP-IML CTCs isolation system, combined with an EGFR immunofluorescence assay of antitumor marker, can serve as a brand-new method for the identification of CTCs for brain tumors. Via lumbar puncture, a minimally invasive procedure, this technique may play a significant role in the clinical diagnosis and drug evaluation of brain tumors.

1 June 2019 in Lung Cancer
Verified
Journal Article
Closed access
SCShaohua Cui
Shaohua Cui
YNYiqian Ni
Yiqian Ni
YZYizhuo Zhao
Yizhuo Zhao
ZLZonghai Li
Zonghai Li
LXLiwen Xiong
Liwen Xiong
LJLiyan Jiang
Liyan Jiang

1 January 2012 in Acta Physico-Chimica Sinica
Verified
Journal Article
Closed access
PDF file
XLXiaofei Liang
Xiaofei Liang
HJHu Jing-Ying
Hu Jing-Ying
CFChen Fu-Hua
Chen Fu-Hua
LZLi Zong-Hai
Li Zong-Hai
JCJin Chang
Jin Chang

1 June 2018 in Journal of Biomedical Nanotechnology
Verified
Journal Article
Closed access
TJTinghui Jiang
Tinghui Jiang
QLQiuying Li
Qiuying Li
PXPing Xiao
Ping Xiao
YLYan Liu
Yan Liu
KWKai Wang
Kai Wang
XSXianjun Sun
Xianjun Sun
Circulating tumour cells isolated from the peripheral blood of patients have the advantage of being non-invasive. The aim of this study was to develop an effective method for detecting pancreatic cancer micrometastasis from peripheral blood and explore the clinical application value of the separation of circulating pancreatic cancer cells using epithelial cell adhesion molecule (EpCAM) lipid magnetic spheres (ELMS) and plastin monoclonal antibody for identification. The pancreatic cancer PANC-1 cells were respectively added to phosphate-buffered saline (PBS) and fresh blood provided by healthy volunteers to detect cell recovery using ELMS. Moreover, trials were conducted using nude mice with tumour and samples from patients with pancreatic cancer to evaluate the effect of CTC isolation and identification. The prepared ELMS captured PANC-1 cells from blood with high efficiency, which was similar to the efficiency obtained with nude mice with tumour and the samples from patients with pancreatic cancer, in agreement with the clinical test results. This study is based on the high efficiency of the EpCAM magnetic nanolipid sphere separation system capturing CTC of pancreatic cancer, which provides a strong support for investigating pancreatic cancer, in terms of its early diagnosis, preoperative and post-operative analysis and analysing the treatment effects.